Ceribell Inc
Health Care · NASDAQ NMS - GLOBAL MARKET · $949M market value · ranked 8 of 25 on today’s screen
Assembled from the data feed — an industry label, a set of filed figures and a price history. It is not a description of what the business does, because nothing in this system reads about the business.
revenue up +31.7% over the last twelve months, +50.9% a year over three years and the latest quarter running +0.8 points against that trend. Ranked against its own industry group (Health), not against the whole market, so a sector where everyone grows fast earns nobody a high mark.
up +35.9% over 13 weeks, +45.3% over 26 and measured against a volatility of 47%. A big move in a jumpy stock counts for less than the same move in a steady one.
debt to equity 0.16, operating margin moving from -65.6% to -68.6% and cash of $3.38 a share. Whether the share count has been growing also counts, and leverage is judged against its own industry.
Each mark is a percentile against the other eligible companies measured today — 80 means it beat four out of five of them on that part, not that it scored 80 out of 100. The set it is ranked against changes daily, so a mark can move without the company changing at all.
one twenty-fifth of the book, the same as every other holding. The company’s identity never enters.
from its rank alone — 8 of 25 — on a straight ramp from 1.5× equal weight at the top to 0.6× at the bottom. The weights are then pushed back inside those bounds and the difference redistributed until they both fit the bounds AND add to 100%, which is why the figure above will not usually equal the ramp value on its own. The size of its score lead is deliberately ignored: the ranking is what a score of this kind can honestly assert; the gaps between scores are not.
Simulated holding right now: F 4.22%.
measured from this company’s own price history
the annual figure divided by the square root of 52
far enough out that ordinary weekly noise does not trigger it
inside the bounds, so it stands unchanged
Books C and E sell it if it trades 19.6% below its highest point since purchase — from today’s $25.04 that would be $20.13. The mark it falls from is the day’s high and the test is against the day’s low, so a break through the level during the day sells the holding even if it recovers by the close. The level rises with the price and never falls, though the distance itself moves with the name’s volatility. Books A, B and D hold it through anything, on purpose: they are the control that shows whether stopping out helped or simply sold the dips. A simulated stop is optimistic — real ones gap through in stocks this thin, which is why an extra 75 basis points is charged on every stop exit and books C and E should still be read as a best case.